Clinical value of combined detection of serum HE4,CA125,CA72-4 and IL-6 in diagnosis of ovarian malignant tumor
10.3969/j.issn.1673-4130.2015.06.016
- VernacularTitle:联合检测血清 HE4、CA125、CA72-4及 IL-6在卵巢恶性肿瘤诊断中的应用价值
- Author:
Wenjie YANG
;
Zhenfu KE
;
Guoying QIU
;
Shu LI
;
Yuping LIU
- Publication Type:Journal Article
- Keywords:
ovarian cancer;
human epididymis protein 4;
interleukin 6
- From:
International Journal of Laboratory Medicine
2015;(6):755-757
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the application value of the combined detection of serum HE4 ,CAl25 ,CA72‐4 and IL‐6 in the di‐agnosis of ovarian malignant tumor .Methods The serum levels of CA125 and CA72‐4 were determined by ECLI ,and the serum levels of HE4 and IL‐6 were determined by ELISA in 32 patients with ovarian cancer ,56 patients with benign ovarian disease and 40 healthy controls .The detection results were performed the statistical analysis .Results The serum levels of HE4 ,CAl25 ,CA72‐4 and IL‐6 in the ovarian cancer group were significantly higher than those in the other two groups with statistically significant differ‐ences(P< 0 .01) ;the sensitivity of CA125 detection in the single index detections was highest(75 .0% ) ,the specificity of HE4 was highest(83 .9% ) ,the highest diagnostic efficiency of single index detection was 79 .5% .The sensitivity ,specificity and efficiency of the combined detection for diagnosis were 96 .9% ,71 .4% and 80 .7% .Except the specificity ,the sensitivity and diagnostic efficien‐cy of the combined detection were higher than those of any one of single index detection .Conclusion The combined detection of se‐rum HE4 ,CAl25 ,CA72‐4 and IL‐6 could increase the diagnostic efficiency of ovarian cancer and conduces to the diagnosis and help to the diagnosis and differential diagnosis of ovarian malignancies .
